Equibles does not estimate personal net worth.
Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLSI alertsDavid B. Patience is recorded as CFO at TriSalus Life Sciences, Inc. (TLSI). The proxy statement of TriSalus Life Sciences, Inc. reports total compensation of $3,443,628 for David B. Patience in fiscal 2025, including a base salary of $268,462. Disclosed compensation is on record for 2 fiscal years. David B. Patience has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for TriSalus Life Sciences, Inc. on August 12, 2026. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Mary Szela (CEO and Board Member), Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member) and 7 others.
“Yeah, as a reminder for everyone, we took on a pretty substantial commercial expansion in the first half of the year.”
“Revenue for the second quarter was $11.4 million, up 1.7 percent, compared to $11.2 million in the prior year period, driven by increasing demand for our innovative drug delivery technology, TRINAP.”
“Let me walk through the results for the first quarter ended March 31, 2026. Revenue for the first quarter was $8.9 million compared to $9.2 million in the prior year period.”
“As Mary mentioned earlier, our results for both the fourth quarter and 2025 fiscal year were strong. Turning first to our results for the quarter, revenue was $13.2 million representing a 60% year-over-year increase over the $8.3 million recorded in the prior period.”
“As Mary mentioned earlier, Trisalus delivered another strong quarter. For the three-month-ended September 30, 2025, revenue was $11.6 million, representing 57% year-over-year growth and 3% sequential growth versus the second quarter.”
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TriSalus Life Sciences, Inc. (TLSI) | CFO | $268,462 | $3,443,628 |
| 2024 | TriSalus Life Sciences, Inc. (TLSI) | CFO | — | — |
